Blackstone Inc. (NEO:BX)

Sage Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-	2,777	1,391	1,748	5,857	1,045
Depreciation & Amortization, Total	-	134.77	134.18	136.3	127.07	106.15
Gain (Loss) On Sale of Investments	-	-4,660	-2,306	-4,646	-8,698	-2,415
Stock-Based Compensation	-	3,110	1,461	1,778	6,797	1,154
Change in Accounts Receivable	-	-78.28	237.62	177.83	288.31	70.05
Change in Accounts Payable	-	194.58	-40.28	158.02	110.96	119.91
Change in Other Net Operating Assets	-	257.39	1,364	3,718	1,791	230.81
Other Operating Activities	-	1,746	1,816	3,266	-2,288	1,624
Operating Cash Flow	-	3,482	4,057	6,336	3,986	1,936
Capital Expenditures	-	-61.41	-224.23	-235.5	-64.32	-111.65
Cash Acquisitions	-	-	-5.42	-	-	-55.17
Investing Cash Flow	-	-61.41	-229.65	-235.5	-64.32	-166.82
Long-Term Debt Issued	-	741.17	494.98	3,522	2,223	888.64
Long-Term Debt Repaid	-	-103.22	-502.46	-280.77	-	-1.89
Net Debt Issued (Repaid)	-	637.95	-7.49	3,241	2,223	886.75
Repurchase of Common Stock	-	-661.07	-418.02	-465.96	-1,273	-504.91
Common Dividends Paid	-	-2,629	-2,478	-3,647	-2,545	-1,319
Other Financing Activities	-	-1,849	-2,150	-2,922	-2,181	-1,307
Financing Cash Flow	-	-4,502	-5,054	-3,794	-3,777	-2,244
Foreign Exchange Rate Adjustments	-	-14.56	4.99	-12.32	-9.81	15.72
Net Cash Flow	-	-1,096	-1,222	2,294	135.28	-459.2
Free Cash Flow	-	3,420	3,833	6,101	3,922	1,824
Free Cash Flow Growth	-	-10.76%	-37.18%	55.56%	114.97%	-4.13%
Free Cash Flow Margin	-	27.01%	49.88%	76.11%	17.68%	29.48%
Free Cash Flow Per Share	-	4.46	5.07	8.23	5.45	2.59
Cash Interest Paid	-	407.33	400.33	261.89	194.17	176.62
Cash Income Tax Paid	-	646.87	569.38	683.17	700.69	209.18

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.